《NEJM,3月30日,Covid-19 in Critically Ill Patients in the Seattle Region — Case Series》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-03-31
  • Covid-19 in Critically Ill Patients in the Seattle Region — Case Series

    List of authors.

    Pavan K. Bhatraju, M.D., Bijan J. Ghassemieh, M.D., Michelle Nichols, M.D., Richard Kim, M.D., Keith R. Jerome, M.D., Arun K. Nalla, Ph.D., Alexander L. Greninger, M.D., Sudhakar Pipavath, M.D., Mark M. Wurfel, M.D., Ph.D., Laura Evans, M.D., Patricia M. Kritek, M.D., T. Eoin West, M.D., M.P.H., et al.

    Abstract

    BACKGROUND

    Community transmission of coronavirus 2019 (Covid-19) was detected in the state of Washington in February 2020.

    METHODS

    We identified patients from nine Seattle-area hospitals who were admitted to the intensive care unit (ICU) with confirmed infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Clinical data were obtained through review of medical records. The data reported here are those available through March 23, 2020. Each patient had at least 14 days of follow-up.

  • 原文来源:https://www.nejm.org/doi/full/10.1056/NEJMoa2004500?query=featured_home
相关报告
  • 《JAMA,3月19日,Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-03-20
    • Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State Matt Arentz, MD1; Eric Yim, MD2; Lindy Klaff, MD2; et alSharukh Lokhandwala, MD, MSc2; Francis X. Riedo, MD2; Maria Chong, MD3; Melissa Lee, MD2 JAMA. Published online March 19, 2020. doi:10.1001/jama.2020.4326 The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the disease it causes, coronavirus disease 2019 (COVID-19), is an emerging health threat.1 Until February 2020, most cases were described in non-US health systems.2,3 One of the first deaths in the US was reported at Evergreen Hospital in Kirkland, Washington. Over the following weeks, multiple cases of COVID-19 were identified in the surrounding community and treated at Evergreen Hospital. Most were attributed to US transmission, and the majority were linked to exposures at a skilled nursing facility.
  • 《JAMA,3月23日,Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-24
    • Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy Graziano Onder, MD, PhD1; Giovanni Rezza, MD2; Silvio Brusaferro, MD3 Author Affiliations Article Information JAMA. Published online March 23, 2020. doi:10.1001/jama.2020.4683 Only 3 cases of coronavirus disease 2019 (COVID-19) were identified in Italy in the first half of February 2020 and all involved people who had recently traveled to China. On February 20, 2020, a severe case of pneumonia due to SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) was diagnosed in northern Italy’s Lombardy region in a man in his 30s who had no history of possible exposure abroad. Within 14 days, many other cases of COVID-19 in the surrounding area were diagnosed, including a substantial number of critically ill patients.1 On the basis of the number of cases and of the advanced stage of the disease it was hypothesized that the virus had been circulating within the population since January.